Viville C, Fornoff H, Bellocq J P
J Urol (Paris). 1986;92(5):275-80.
Analysis of 600 case-reports of urine cytology (micturitional samples in 597 cases and pyelo-ureteral brushings in 3) was in relation to 137 patients with carcinoma of urinary excretory pathways and 463 with various lesions representing the full range of urinary tract disease. Two conclusions can be drawn. First, urine cytology is a very effective means of surveillance of patients treated for carcinoma of urinary tract excretory pathways: until results are regularly negative the prognosis must be reserved whatever is found on cystoscopy or even in frozen biopsy specimens. Second, cytology is not valid for routine screening of these tumors: no case was detected on its results alone and false positives were numerous. The principal use for urine cytology is still the regular, prolonged surveillance of patients treated for bladder tumor.
对600例尿细胞学报告（597例为排尿样本，3例为肾盂输尿管刷检样本）进行分析，这些报告来自137例尿路排泄途径癌患者和463例患有代表整个泌尿系统疾病范围的各种病变的患者。可以得出两个结论。第一，尿细胞学是监测接受尿路排泄途径癌治疗患者的一种非常有效的手段：在结果定期呈阴性之前，无论膀胱镜检查甚至冰冻活检标本中发现了什么，预后都必须谨慎判断。第二，细胞学对这些肿瘤的常规筛查无效：仅根据其结果未检测到任何病例，且假阳性众多。尿细胞学的主要用途仍然是对接受膀胱肿瘤治疗的患者进行定期、长期的监测。
